Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT: A phase-2 trial

P Gimsing; Ø Hjertner; N Abildgaard; N F Andersen; T G Dahl; H Gregersen; T W Klausen; U-H Mellqvist; O Linder; R Lindås; N Tøffner Clausen; S Lenhoff

doi:10.1038/bmt.2015.125

Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT: A phase-2 trial

P Gimsing, Ø Hjertner, N Abildgaard, N F Andersen, T G Dahl, H Gregersen, T W Klausen, U-H Mellqvist, O Linder, R Lindås, N Tøffner Clausen, S Lenhoff

Research output: Contribution to journal › Journal article › Research › peer-review

10 Citations (Scopus)

Original language	English
Journal	Bone Marrow Transplantation
Volume	50
Issue number	10
Pages (from-to)	1306-1311
Number of pages	6
ISSN	0268-3369
DOIs	https://doi.org/10.1038/bmt.2015.125
Publication status	Published - 2015

Access to Document

10.1038/bmt.2015.125

Fingerprint Dive into the research topics of 'Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT: A phase-2 trial'. Together they form a unique fingerprint.

Cite this

Gimsing, P., Hjertner, Ø., Abildgaard, N., Andersen, N. F., Dahl, T. G., Gregersen, H., Klausen, T. W., Mellqvist, U-H., Linder, O., Lindås, R., Tøffner Clausen, N., & Lenhoff, S. (2015). Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT: A phase-2 trial. Bone Marrow Transplantation, 50(10), 1306-1311. https://doi.org/10.1038/bmt.2015.125

Gimsing, P ; Hjertner, Ø ; Abildgaard, N ; Andersen, N F ; Dahl, T G ; Gregersen, H ; Klausen, T W ; Mellqvist, U-H ; Linder, O ; Lindås, R ; Tøffner Clausen, N ; Lenhoff, S. / Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT : A phase-2 trial. In: Bone Marrow Transplantation. 2015 ; Vol. 50, No. 10. pp. 1306-1311.

@article{df9858ce4d3e49cfbc3c48dd88c421f0,

title = "Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT: A phase-2 trial",

author = "P Gimsing and {\O} Hjertner and N Abildgaard and Andersen, {N F} and Dahl, {T G} and H Gregersen and Klausen, {T W} and U-H Mellqvist and O Linder and R Lind{\aa}s and {T{\o}ffner Clausen}, N and S Lenhoff",

year = "2015",

doi = "10.1038/bmt.2015.125",

language = "English",

volume = "50",

pages = "1306--1311",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "10",

}

Gimsing, P, Hjertner, Ø, Abildgaard, N, Andersen, NF, Dahl, TG, Gregersen, H, Klausen, TW, Mellqvist, U-H, Linder, O, Lindås, R, Tøffner Clausen, N & Lenhoff, S 2015, 'Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT: A phase-2 trial', Bone Marrow Transplantation, vol. 50, no. 10, pp. 1306-1311. https://doi.org/10.1038/bmt.2015.125

Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT : A phase-2 trial. / Gimsing, P; Hjertner, Ø; Abildgaard, N; Andersen, N F; Dahl, T G; Gregersen, H; Klausen, T W; Mellqvist, U-H; Linder, O; Lindås, R; Tøffner Clausen, N; Lenhoff, S.

In: Bone Marrow Transplantation, Vol. 50, No. 10, 2015, p. 1306-1311.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT

T2 - A phase-2 trial

AU - Gimsing, P

AU - Hjertner, Ø

AU - Abildgaard, N

AU - Andersen, N F

AU - Dahl, T G

AU - Gregersen, H

AU - Klausen, T W

AU - Mellqvist, U-H

AU - Linder, O

AU - Lindås, R

AU - Tøffner Clausen, N

AU - Lenhoff, S

PY - 2015

Y1 - 2015

U2 - 10.1038/bmt.2015.125

DO - 10.1038/bmt.2015.125

M3 - Journal article

C2 - 26121108

VL - 50

SP - 1306

EP - 1311

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 10

ER -